The FDA gave approval to market Sildenafil for Oral Suspension, 10mg/mL, a generic of Pfizer’s Revatio for oral suspension which is currently listed on the FDA’s drug shortages list.
Use of the dry powder formulation of treprostinil, known as LIQ861, has demonstrated safety and tolerability in patients with pulmonary arterial hypertension beyond 2 weeks.
The cardiopulmonary reserve index is an effective predictor of prognosis in patients with pulmonary hypertension, particularly when pulmonary hypertension is caused by left heart disease.
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
Traffic-related air pollution exposure has been linked to baseline disease severity in idiopathic/heritable pulmonary arterial hypertension.
Serum brain natriuretic peptide and echocardiographic evaluation performed at the time of bronchopulmonary dysplasia diagnosis can detect the development of late pulmonary hypertension in infants.
CMR-determined RV strain may be a promising non-invasive method to assess RV-arterial coupling in PH.
Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm.
Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.
Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.
